Alnylam Pharmaceuticals, Inc.

Pharmaceutical company · Cambridge, Massachusetts, United States · Nasdaq: ALNY

Alnylam Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its shares trade on Nasdaq under the ticker ALNY. The US FDA lists 1 drug manufacturing or testing site registered to the company. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $590,073 in total, most recently in 2006.

Profile compiled from public records. Is this your company? Request a correction or update

Alnylam Pharmaceuticals at a glance

Typepharmaceutical company
HeadquartersCambridge, Massachusetts, United States
Stock listingNasdaq: ALNY
SEC industryPharmaceutical Preparations
FDA-registered sites1
SEC CIK1178670

What does Alnylam Pharmaceuticals do?

Operations at its FDA-registered drug sites

AnalysisManufacturing

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $590,073 in total (2006).

Where is Alnylam Pharmaceuticals located?

Headquarters: Cambridge, Massachusetts, United States

  • Cambridge, MassachusettsAlnylam Pharmaceuticals Inc. · FDA drug site

Frequently asked questions about Alnylam Pharmaceuticals

Where is Alnylam Pharmaceuticals headquartered?

Alnylam Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts, United States.

What does Alnylam Pharmaceuticals do?

Alnylam Pharmaceuticals, Inc. is a pharmaceutical company. Its FDA-registered drug sites are registered for analysis and manufacturing. Its SEC industry classification is Pharmaceutical Preparations.

Is Alnylam Pharmaceuticals a public company?

Yes. Alnylam Pharmaceuticals, Inc. trades on Nasdaq under the ticker ALNY.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.

Alnylam Pharmaceuticals: Headquarters, Locations & Company Profile (2026) | BioBridgeX